Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)

42
Real-time Quote. Real-time Tradegate - 08/01 04:01:59 pm
63.681 EUR   -4.07%
15h ago MERCK KGAA : EMD Millipore Assigned Patent
15h ago MERCK KGAA : Zymogenetics, Ares Trading Assigned Patent
1d ago MERCK KGAA : Ready-to-Use EZ-Fit Filtration Unit from EMD Millipore Leverag..
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
07/28/2014 07/29/2014 07/30/2014 07/31/2014 08/01/2014 Date
65.21(c) 65.57(c) 66.38(c) 66.38(c) 63.97(c) Last
721 192 573 836 684 300 884 598 1 275 884 Volume
+1.29% +0.55% +1.24% 0.00% -3.63% Change
More quotes
Company
Merck KGaA operates as a pharmaceutical, chemical and life science company, which engages in the research and development of innovative drugs and chemicals. The company operates through four divisions: Merck Serono, Consumer Health, Performance Materials & Merck Millipore. The Merck Serono division... 
Sector
Pharmaceuticals
Calendar
08/13Earnings Release
Surperformance© rating of Merck KGaA
Trading Rating : Investor Rating :
More about the company
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 11 247 M
EBIT 2014 2 264 M
Net income 2014 1 456 M
Debt 2014 605 M
Yield 2014 1,52%
Sales 2015 11 601 M
EBIT 2015 2 372 M
Net income 2015 1 563 M
Finance 2015 264 M
Yield 2015 1,63%
PER 2014 21,15
PER 2015 19,24
EV / Sales 2014 0,82x
EV / Sales 2015 0,72x
Capitalization 8 579 M
More Financials
Latest news on MERCK KGAA
15h ago MERCK KGAA : EMD Millipore Assigned Patent
15h ago MERCK KGAA : Zymogenetics, Ares Trading Assigned Patent
1d ago MERCK KGAA : Ready-to-Use EZ-Fit Filtration Unit from EMD Millipore Leverages In..
3d ago MERCK KGAA : CEO Karl-Ludwig Kley and German Federal Economics Minister Sigmar G..
3d ago MERCK KGAA : Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C ..
3d ago MERCK KGAA : EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB00107..
4d ago MERCK KGAA : CEO Karl-Ludwig Kley and German Federal Economics Minister Sigmar G..
4d ago MERCK KGAA : CEO Karl-Ludwig Kley and German Federal Economics Minister Sigmar G..
6d ago MERCK KGAA : aims to hike revenues in China to 1 billion euro by 2018
6d ago MERCK KGAA : aims to hike revenues in China to one billion euro by 2018
07/24 MERCK KGAA : Study Data from Merck KGaA Provide New Insights into Chromatography..
07/24 MERCK KGAA : Serono Announces Collaboration with San Raffaele University & Resea..
More news
4-Traders Strategies on MERCK KGAA 
04/10Prices move higher as positive news are released
03/10A gap-filling is anticipated
More Strategies
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
Merck KGaA : Income Statement Evolution
More Financials
EPS Revisions
Merck KGaA : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF